Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

A three-point identity criteria tool for establishing product identity using icIEF method.

Ahluwalia D, Belakavadi M, Das TK, Katiyar A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Apr 15;1083:271-277. doi: 10.1016/j.jchromb.2018.02.042. Epub 2018 Mar 1.

PMID:
29554523
2.

Identification of a host cell protein impurity in therapeutic protein, P1.

Ahluwalia D, Dhillon H, Slaney T, Song H, Boux H, Mehta S, Zhang L, Valdez A, Krishnamurthy G.

J Pharm Biomed Anal. 2017 Jul 15;141:32-38. doi: 10.1016/j.jpba.2017.03.065. Epub 2017 Apr 9.

PMID:
28419935
3.

Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models.

Sun JD, Liu Q, Ahluwalia D, Ferraro DJ, Wang Y, Jung D, Matteucci MD, Hart CP.

Cancer Biol Ther. 2016 Apr 2;17(4):371-80. doi: 10.1080/15384047.2016.1139268. Epub 2016 Jan 28.

4.

Combination treatment with hypoxia-activated prodrug evofosfamide (TH-302) and mTOR inhibitors results in enhanced antitumor efficacy in preclinical renal cell carcinoma models.

Sun JD, Ahluwalia D, Liu Q, Li W, Wang Y, Meng F, Bhupathi D, Matteucci MD, Hart CP.

Am J Cancer Res. 2015 Jun 15;5(7):2139-55. eCollection 2015.

5.

Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition.

Meng F, Bhupathi D, Sun JD, Liu Q, Ahluwalia D, Wang Y, Matteucci MD, Hart CP.

BMC Cancer. 2015 May 21;15:422. doi: 10.1186/s12885-015-1387-6.

6.

Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer.

Sun JD, Liu Q, Ahluwalia D, Li W, Meng F, Wang Y, Bhupathi D, Ruprell AS, Hart CP.

Cancer Biol Ther. 2015;16(3):438-49. doi: 10.1080/15384047.2014.1003005.

7.

Hypermutability and error catastrophe due to defects in ribonucleotide reductase.

Ahluwalia D, Schaaper RM.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18596-601. doi: 10.1073/pnas.1310849110. Epub 2013 Oct 28.

8.

Novel mutator mutants of E. coli nrdAB ribonucleotide reductase: insight into allosteric regulation and control of mutation rates.

Ahluwalia D, Bienstock RJ, Schaaper RM.

DNA Repair (Amst). 2012 May 1;11(5):480-7. doi: 10.1016/j.dnarep.2012.02.001. Epub 2012 Mar 13.

9.

TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules.

Liu Q, Sun JD, Wang J, Ahluwalia D, Baker AF, Cranmer LD, Ferraro D, Wang Y, Duan JX, Ammons WS, Curd JG, Matteucci MD, Hart CP.

Cancer Chemother Pharmacol. 2012 Jun;69(6):1487-98. doi: 10.1007/s00280-012-1852-8. Epub 2012 Mar 2.

10.

Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer.

Sun JD, Liu Q, Wang J, Ahluwalia D, Ferraro D, Wang Y, Duan JX, Ammons WS, Curd JG, Matteucci MD, Hart CP.

Clin Cancer Res. 2012 Feb 1;18(3):758-70. doi: 10.1158/1078-0432.CCR-11-1980. Epub 2011 Dec 19.

11.

14-Aminocamptothecins: their synthesis, preclinical activity, and potential use for cancer treatment.

Duan JX, Cai X, Meng F, Sun JD, Liu Q, Jung D, Jiao H, Matteucci J, Jung B, Bhupathi D, Ahluwalia D, Huang H, Hart CP, Matteucci M.

J Med Chem. 2011 Mar 24;54(6):1715-23. doi: 10.1021/jm101354u. Epub 2011 Feb 22.

PMID:
21341674
12.

Effects of intravenous and inhaled levosimendan in severe rodent sepsis.

Scheiermann P, Ahluwalia D, Hoegl S, Dolfen A, Revermann M, Zwissler B, Muhl H, Boost KA, Hofstetter C.

Intensive Care Med. 2009 Aug;35(8):1412-9. doi: 10.1007/s00134-009-1481-9. Epub 2009 Apr 15.

PMID:
19367398
13.

Cecal ligation and incision: an acute onset model of severe sepsis in rats.

Scheiermann P, Hoegl S, Revermann M, Ahluwalia D, Zander J, Boost KA, Nguyen T, Zwissler B, Muhl H, Hofstetter C.

J Surg Res. 2009 Jan;151(1):132-7. doi: 10.1016/j.jss.2008.02.032. Epub 2008 Mar 18.

PMID:
18486152
14.

Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair.

Rajasingh J, Lambers E, Hamada H, Bord E, Thorne T, Goukassian I, Krishnamurthy P, Rosen KM, Ahluwalia D, Zhu Y, Qin G, Losordo DW, Kishore R.

Circ Res. 2008 Jun 6;102(11):e107-17. doi: 10.1161/CIRCRESAHA.108.176115. Epub 2008 May 15.

15.

Knee posture predicted from subchondral apparent density in the distal femur: an experimental validation.

Polk JD, Blumenfeld J, Ahluwalia K.

Anat Rec (Hoboken). 2008 Mar;291(3):293-302. doi: 10.1002/ar.20653. Erratum in: Anat Rec (Hoboken). 2008 Jul;291(7):894. Ahluwalia, D [corrected to Ahluwalia, K].

16.

Enhanced voluntary alcohol consumption after estrogen supplementation negates estrogen-mediated vascular repair in ovariectomized mice.

Rajasingh J, Bord E, Qin G, Ii M, Silver M, Hamada H, Ahluwalia D, Goukassian D, Zhu Y, Losordo DW, Kishore R.

Endocrinology. 2007 Aug;148(8):3618-24. Epub 2007 May 3.

PMID:
17478555
17.

Front-form spinors in the Weinberg-Soper formalism and generalized Melosh transformations for any spin.

Ahluwalia DV, Sawicki M.

Phys Rev D Part Fields. 1993 Jun 1;47(11):5161-5168. No abstract available.

PMID:
10015527
18.

Phenomenological approach to high-spin quantum fields based on the Weinberg formalism.

Ahluwalia DV, Ernst DJ.

Phys Rev C Nucl Phys. 1992 Jun;45(6):3010-3012. No abstract available.

PMID:
9968069
19.

Vagal influence in gastric acid secretion in normals and in duodenal ulcer patients.

Singh H, Goyal RK, Ahluwalia DS, Chuttani HK.

Gut. 1968 Oct;9(5):604-8. No abstract available.

20.
21.

An investigation into dental and oral disorders of children of Rangoon.

AHLUWALIA DS.

Burma Med J. 1957 Jan;5(1):38-42. No abstract available.

PMID:
13413687
22.

Place of dental science in general medical practice.

AHLUWALIA DS.

Burma Med J. 1956 Apr;4(2):24-8. No abstract available.

PMID:
13329909

Supplemental Content

Loading ...
Support Center